Edwardsiella tarda is one of the leading marine pathogens that can infect a wide range of cultured marine species. In this study, the acrR-acrAB cluster was cloned from TX1, a pathogenic E. tarda strain isolated from diseased fi sh. AcrR and AcrAB were found to be involved in resistance against acrifl avine and methyl viologen, which positively regulate the expression of acrAB. AcrR negatively regulates its own expression and the expression of the acrAB operon, most likely by interacting with a 24-bp operator site that overlaps the putative promoter of acrA (P acrA ). The repressive effect of AcrR on P acrA could be relieved by acrifl avine, methyl viologen, and ethidium bromide, the presence of each of which enhanced transcription from P acrA . Interruption of the regulated expression of acrR by introducing into TX1 a plasmid that overexpresses acrR affected growth under stress conditions, AI-2 production, and bacterial virulence. In addition, mutational analyses identifi ed a constitutively active AcrR mutant (named N215), which exhibits full repressor activity but is impaired in its ability to interact with the inducer. Overexpression of N215 produced the same kind of but moderately stronger effect on TX1 compared to that produced by overexpression of the wild-type acrR.
Introduction
To date several classes of multidrug exporters have been identifi ed in prokaryotic cells, one of which is the resistance nodulation division (RND) family transporters (Poole and Srikumar, 2001) . In this type of effl ux system, RND, an inner membrane proton-drug antiporter, forms a tripartite construct with a channel-forming outer membrane protein and an inner membrane protein of the MFP (membrane fusion protein) family (Eswaran et al., 2004) . To this class of effl ux pump belongs the AcrAB-TolC complex, in which AcrB, a cytoplasmic protein of the RND family , cooperates with the outer membrane channel protein TolC (Fralick, 1996; Koronakis et al., 2000; Tikhonova and Zgurskaya, 2004) and the MFP family protein AcrA to form an effl ux pump that is effective against a broad range of antimicrobial agents and toxic compounds, resulting in the Mar (multiple antibiotic resistance) phenotype (Nikaido, 1996; Randall and Woodward, 2002) .
In Escherichia coli the expression of the acrAB operon is controlled at multiple levels via several distinct mechanisms. On a general scale, it is modulated by stress conditions (Ma et al., 1996) and the XylS/AraC family regulators MarA (Barbosa and Levy, 2000) , SoxS (White et al., 1997) , Rob (Rosenberg et al., 2003) , and SidA (Rahmati et al., 2002; Wei et al., 2001) ; on a local level the expression of the acrAB is controlled by the transcription repressor AcrR, a member of the TetR family of transcription regulators. The TetR family of regulators possesses two functional domains, the N terminal helix-turn-helix DNA binding domain and the C terminal effector-binding domain (Grkovic et al., 2002; Orth et al., 2000) . Binding of the effector (or inducer) to the effector domain presumably alters the structural topology of the regulator and thus affects its ability to interact with DNA.
Edwardsiella tarda is a Gram-negative pathogen with a broad range of hosts that includes animals and humans. As the causative agent of edwardsiellosis, a serious systematic disease of cultured fi sh and other animal species, E. tarda has in recent years been recognized as one of the major marine pathogens that cause severe losses to aquaculture industries worldwide. Several virulence systems and factors have been identifi ed in E. tarda, but only a few studies on the genetic mechanisms of antimicrobial resistance in E. tarda have been documented (Akinbowale et al., 2006; Alcaide et al., 2006; Stock and Wiedemann, 2001) and no link has been established between antimicrobial resistance and virulence in this species. We presented in this report the cloning and genetic analysis of the acrRacrAB cluster from TX1, a pathogenic E. tarda strain isolated from diseased fi sh. Our results indicated that the TX1 AcrR is an auto-regulated transcriptional repressor that controls the expression of the acrAB operon and that disruption of the regulated expression of acrR has an attenuating effect on bacterial virulence.
Materials and Methods
Bacterial strains and growth conditions. The Escherichia coli strain DH5α (TaKaRa) and the Edwardsiella tarda strain TX1 (Zhang et al., 2008) were cultur ed in Luria-Bertani lysis broth (LB) medium (Sambrook et al., 1989) at 37 C and 28 C, respectively. Appropriate antibiotics were supplemented at the following concentrations: ampicillin (Ap), 100 μg ml 1 ; kanamycin (Kn), 50 μg ml 1 ; tetracycline (Tc), 15 μg ml 1 .
Plasmid construction. The plasmids and primers used in this study are listed in Table 1 . The 284 bp DNA fragment immediately upstream of the translational start of acrA and the 141 bp DNA confi ned between acrA and acrR (amplifi ed by PCR with primer pairs TF6/TR5 and TF20/TR13, respectively) were inserted at the SwaI site of pSC11, resulting in pSC284 and pSC141R, respectively. pSC11 and pBT carrying the mutant P acrA , P acrR , acrO, and acrR were constructed by site-directed mutagenesis using the method of overlap extension PCR (Ho et al., 1989) . To construct pAI, the DNA encoding the antisense RNA of the acrAB (amplifi ed by PCR with the primer pair TF29/TR23) was inserted into pBT at the SmaI site, resulting in pBTAI; the SwaI fragment of pBTAI containing the antisense acrAB was inserted at the EcoRV site of pJRA, yielding pAI. pAR was generated by inserting the acrR gene into pBT at the SmaI site. pJT48 and pJN215 were created by inserting the acrR-containing SwaI fragments of pAR and pARD22, respectively, into pJRA at the EcoRV site.
Cloning of the acrR-acrAB cluster. TX1 genomic DNA was digested with Sau3A1 and the fragments between 4 and 6 kb were ligated into pBU at the BamHI site. DH5α was transformed with the ligation mix and the transformants were selected as described previously (Zhang and Sun, 2007) . The complete sequence of the acrR-acrAB cluster was obtained by genome walking as described previously (Zhang and Sun, 2007) .
Quantitative real time PCR (qRT-PCR). Total RNA was extracted from fi sh livers and from cells grown in LB medium to OD 600 of 0.8 by using the SV total RNA isolation system (Promega). qRT-PCR was carried out in an ABI 7300 Real-time Detection System (Applied Biosystems) by using the SYBR ExScript RT-PCR Kit (TaKaRa). Each assay was performed in triplicate with 16S rRNA as a control. Data analyses were performed as described previously (Zhang et al., 2008) . All data were given in terms of relative mRNA expressed as means plus or minus standard errors of the means (SE). Statistical analyses were performed by using the two-tailed t-test.
β-Galactosidase assay. This was carried out as described previously (Sun et al., 1998) .
Experimental infection. Japanese fl ounder, weighing 13 g each, were randomly divided into several groups (5 fi sh/group). Each group was injected intraperitonealy (i.p.) with 1 10 5 CFU of TX1/pJRA or TX1/ pJT48 or TX1/pJN215 that had been cultured to OD 600 of 0.5 in LB medium, washed, and resuspended in phosphate-buffered saline (PBS). To examine bacterial dissemination, the livers of the infected fi sh were removed under sterile conditions and homogenized with glass homogenizers. The homogenates were plated on LB plates supplemented with ampicillin and tetracycline. After incubation at 28 C for 48 h, the colonies that appeared on the plates were enumerated. The nature of these colonies was verifi ed by PCR analysis of 20 colonies randomly selected from each plate using primers specifi c to TX1 and the plasmid; one of the 20 PCR products was subsequently analyzed by DNA sequencing. Statistical analysis was performed by using the t-test.
AI-2 assay. This was carried out as described previously (Zhang et al., 2008) . Briefl y, overnight cultures of bacteria grown in LB medium at 28 C were diluted 1 100 in fresh LB medium; 2 ml of cell culture was taken every 30 min, from which the cell-free supernatant was obtained by centrifugation and then fi ltering through a 0.22-μm fi lter (Millipore). For measurement of bioluminescence induction, overnight culture of the V. harveyi strain BB170 (American Type Culture Collection (ATCC)) grown in AB medium at 28 C was diluted 1 5,000 in fresh AB medium supplemented with 10% cell-free supernatant (as prepared above) of the tested strains or with the growth medium (as the control). The growth was continued and light production was measured by using a Glomax luminometer (Promega).
Bacterial conjugation. pJRA and its variants were introduced into the E. coli strain S17-1λpir (Biomedal, Spain) by transformation. The transformants and TX1 were grown in LB medium to an OD 600 of 1 and mixed in 1 1 ratio. The mixed cells were washed and resuspended in 10 mM MgSO 4 and dropped onto a LB plate. After incubation at 28 C for 12 h, the growth on the plate was scraped off and resuspended in 1 ml LB, from which 100 μl was taken and spread onto a LB plate supplemented with ampicillin and tetracycline. The plate was incubated at 28 C for 48 h, and the colonies that appeared were verifi ed to be authentic transconjugants by PCR and sequence analysis of the PCR products.
Database search and nucleotide sequence accession numbers. A database search was conducted using the BLAST programs at the NCBI (National Cen- 
Underlined nucleotides are restriction sites of the enzymes indicated in parentheses at the ends of the sequences.
ter for Biotechnology Information). A signal peptide search was performed with the SignalP 3.0 server. The nucleotide sequence of the acrR-acrAB cluster has been deposited in GenBank database under the accession number EU082215.
Results

Characterization of the acrR-acrAB cluster of TX1
The acrR-acrAB cluster of TX1 was cloned via the pBU system, a signal sequence trap developed in our laboratory for the identifi cation of proteins with functional secretion domains (Zhang and Sun, 2007) . pBU is a pBR322-based expression plasmid that carries the coding sequence of a secretion-defective reporter AgaV (an extracellular agarase). Since AgaV lacks its own signal peptide, it remains in the cytoplasm. However, if a heterologous DNA encoding a secretion protein is inserted upstream of and forms an in-frame fusion with agaV, then AgaV may be transported out of the cell as a passenger protein by the fused heterologous protein. Since AgaV, once being secreted out of the cell, can degrade agar, AgaV-secreting colonies have a visible pit around them on LB agar plates and therefore can be easily detected. In the selection of the acrR-acrAB cluster, the TX1 genomic DNA selected by the pBU system is a 1,005 bp DNA covering the 189 bp upstream and the 816 bp downstream of the translation start of acrA (Fig. 1) . The up-and down-stream regions of this 1,005 bp DNA were then obtained by genome walking using primers based on the sequence of this 1,005 bp DNA. In this fashion, the entire acrRacrAB cluster was cloned. Sequence analysis showed that acrA and acrB are arranged in tandem and preceded by acrR, which is transcribed divergently from the former. AcrR, AcrA, and AcrB share the highest sequence identities with their respective counterparts in Yersinia enterocolitica (56%), Salmonella enterica (74%), and Y. enterocolitica (82%) (GenBank accession nos. AM286415 and AL627267, respectively). Putative signal peptide sequences, consisting of the fi rst 24 and 33 amino acid residues respectively, were identifi ed in AcrA and AcrB. Like in many RND family proteins (Tseng et al., 1999; , 12 transmembrane helices were found in AcrB by using the TMHMM Server (v.2.0). Two large periplasmic loops (between the signal peptide and helix 1 and between helices 6 and 7, respectively), which are another characteristic of the RND exporters, were also found in AcrB. These data indicated that the TX1 acrR-acrAB cluster presumably encodes an AcrAB effl ux system similar to those identifi ed in other bacterial species.
acrAB expression is required for resistance against acrifl avine and methyl viologen
TX1 exhibits relatively high levels of tolerance to tetracycline, acrifl avine, and methyl viologen (MV) (MICs of 20, 35, and 500 μg/ml, respectively), which are known substrates of some AcrAB effl ux systems (Tsukagoshi and Aono, 2000; White et al., 1997) . To determine whether the TX1 AcrAB was involved in resistance against these compounds, the expression of acrAB was attenuated by antisense RNA interference and its effect on drug resistance was examined. For this purpose, the plasmid pAI, which expresses the antisense RNA of acrAB (corresponding to the region between the translation stop codon of acrB and position 70 relative to the translational start of acrA), was introduced into TX1 via conjugation. Production of the antisense RNA in the transconjugant, TX1/pAI, was confi rmed by qRT-PCR (data not shown). qRT-PCR analyses showed that acrA and acrB expressions in TX1/pAI were reduced 2.9-and 3.8-fold, respectively, compared to those in TX1 harboring the control plasmid pJRA (Fig. 2) . Resistance analyses indicated that TX1/pAI exhibited reduced tolerance to acrifl avine and MV (MICs of 20 and 250 μg/ml, respectively) but retained the same level of resistance to tetracycline. Consistent with this observation, transcription of acrA was signifi cantly enhanced by acrifl avine and MV (Fig.  3) but not affected by tetracycline (data not shown). These results demonstrated that acrAB expression was positively regulated by acrifl avine and MV and that full expression of acrAB was required to achieve the full resistance against acrifl avine and MV observed in the natural state of TX1. These data supported the notion that AcrAB was required for acrifl avine and MV resistance in TX1.
Identifi cation of the putative promoters of acrA and acrR
To locate the promoter of acrA, the 284 bp DNA fragment immediately upstream of the translational start of acrA was cloned into the promoter probe plasmid pSC11 so that in the recombinant plasmid, pSC284, the 284 bp DNA is fused to a promoterless lacZ reporter gene. pSC284 was introduced into the E. coli strain DH5α by transformation, and the transformants formed blue colonies on X-gal plates, suggesting that the 284 bp DNA upstream of acrA possesses an active promoter. Inspection of this DNA fragment revealed a putative σ 70 -dependent promoter (named P acrA ) with CTTACA and TACCAT as the 35 and 10 box, respectively (Fig. 4) . Mutational study indicated that DH5α carrying pSC284M1, which is identical to pSC284 except that the 10 region of P acrA is mutated to TACCTA, which bears less resemblance to the consensus 10 element, exhibited 31-fold less β-galactosidase activity (5 Miller units) than DH5α/pSC284 (160 Miller units) ( Table 2 ). These results suggested that the promoter activity observed with the 284 bp DNA upstream of acrA was conferred by P acrA .
To locate the promoter of acrR, the 141 bp DNA confi ned between acrA and acrR was cloned into pSC11 and the recombinant plasmid, pSC141R, was introduced into DH5α by transformation. The transformant, DH5α/pSC141R, produced 4.2-fold more β-galactosidase activity (672 Miller units) than DH5α/pSC284, Fig. 4 . Nucleotide sequence of the intergenic region between acrR and acrA.
The translation starts of acrR and acrA, respectively, are in capital letters at the ends of the sequence; the acrO site is in italics; the putative 10 and 35 elements of P acrR and P acrA are underlined and in capital letters. 96.4 100 β-Galactosidase assay was performed using cells gown in LB medium with (+) or without ( ) acrifl avine (10 μg/ml) to OD 600 of 1. β-Galactosidase activities are presented as percentages of that of DH5α/pSC284. suggesting that the 141 bp DNA harbored a functional promoter. Consistently, a potential σ 70 -dependent promoter (named P acrR ) was identifi ed in this DNA fragment (Fig. 4) . Mutational analyses indicated that DH5α carrying pSC141RM1, which is identical to pSC141R except that the 10 element (TATAAA) of P acrR is mutated to TAATTA, which is divergent from the consensus 10 element, produced 8-fold less β-galactosidase activity (84 Miller units) than DH5α/pSC141R ( Table 2) , suggesting that the promoter activity of the 141 bp DNA confi ned between acrA and acrR was conferred by P acrR .
AcrR negatively regulates transcription from both P acrA and P acrR
To investigate whether AcrR could regulate acrAB and its own expression, DH5α/pSC284 and DH5α/ pSC141R were transformed separately with the control plasmid pBT and the plasmid pAR, which expresses acrR. Subsequent β-galactosidase assays showed that the β-galactosidase activities of DH5α/pSC284/ pAR and DH5α/pSC141R/pAR (0.5 and 224 Miller units, respectively) were, respectively, 320-and 3-fold lower than those of DH5α/pSC284/pBT and DH5α/ pSC141R/pBT (160 and 670 Miller units, respectively), suggesting that AcrR repressed transcription from both P acrA and P acrR . Consistently, sequence inspection identifi ed a potential AcrR binding site in the form of a 24 bp palindrome-forming sequence (5 -TACATG-CATTGATGAATGTATGTA-3 , designated acrO) that overlaps P acrA (Fig. 4) . To examine the potential significance of acrO in the functioning of AcrR, the dyad symmetry of acrO was disrupted by mutating the TG-CATT sequence to AGGTAA; the plasmid pSC284M3, which carries the 284 bp DNA upstream of acrA bearing the mutated acrO, was introduced into DH5α and DH5α/pAR by transformation. Subsequent β-galactosidase assays showed that the β-galactosidase activity of DH5α/pSC284M3 (151 Miller units) was similar to that of DH5α/pSC284 (160 Miller units) but the β-galactosidase activity of DH5α/pAR/pSC284M3 (138 Miller units) was 276-fold higher than that of DH5α/ pAR/pSC284 (0.5 Miller units). These data demonstrated that mutation of acrO had no impact on the activity of P acrA but abolished the repressive effect of AcrR on P acrA , which suggested that acrO was essential to the interaction between AcrR and P acrA .
Acrifl avine, MV, and ethidium bromide are among the inducers of AcrR
TetR-like proteins are known to respond to certain effector molecules that can interact with and thereby abolish the DNA-binding capacity of the regulator. To fi nd out the inducers of the TX1 AcrR, DH5α/pSC284/ pAR was cultured in the presence of chloramphenicol, streptomycin, tetracycline, acrifl avine, MV, and ethidium bromide, respectively. Subsequent β-galactosidase assay indicated that acrifl avine (10 μg/ml), ethidium bromide (12.5 μg/ml), and MV (80 μg/ml) caused, respectively, 10-, 6-, and 12-fold increase in the β-galactosidase activity of DH5α/pSC284/pAR, suggesting that these compounds could function as AcrR inducers and abolish the ability of AcrR to interact with the target promoter. In contrast, chloramphenicol, streptomycin, and tetracycline had no apparent effect on the β-galactosidase activity of DH5α/pSC284/pAR.
Effect of uncontrolled overexpression of acrR
Since acrR expression is autoregulated, we wondered what would ensue from disruption of this regulation. To investigate this question, the plasmid pJT48, which constitutively expresses acrR, was conjugated into TX1. qRT-PCR analyses showed that acrR expression in the transconjugant, TX1/pJT48, was increased 7-fold whereas that of acrA was decreased 4-fold compared to those in TX1/pJRA, suggesting that in TX1/pJT48, acrR was indeed overexpressed, which in turn repressed the expression of acrA. Growth studies showed that the growth profi le of TX1/pJT48 was similar to that of TX1/pJRA when grown in LB medium but differed from the latter when grown in LB medium supplemented with acrifl avine, under which condition TX1/ pJT48 exhibited slower doubling time and lower maximum cell density (Fig. 5 ). Since our recent study (Zhang et al., 2008) showed that in E. tarda, the LuxS/ AI-2 quorum sensing system is involved in bacterial growth and pathogenicity, we also examined AI-2 production in TX1/pJT48. The result showed that TX1/ pJT48 displayed 8.1-fold less AI-2 activity than TX1/ pJRA.
To investigate whether overexpression of acrR had any effect on bacterial virulence, Japanese fl ounder were infected with the same dose of TX1/pJT48 or TX1/pJRA. The livers of the fi sh were taken at 24 h post-infection and homogenized in PBS. The homogenates were plated on selective LB plates and examined for bacterial recovery. The results showed that the average amount of the recovered TX1/pJT48 was 22-fold lower than that of the recovered TX1/pJRA. To examine whether the difference in bacterial recovery between TX1/pJT48 and TX1/pJRA was due to selective loss of pJT48 during infection, the loss rate of pJT48 was determined. For this purpose, the liver homogenates (as described above) of the TX1/pJT48-infected fi sh were plated on both LB plates supplemented with tetracycline alone (for the selection of TX1 and TX1/ pJT48) and LB plates supplemented with tetracycline plus ampicillin (for the selection of TX1/pJT48). The result showed that the number of TX1/pJT48 that appeared on the tetracycline plus ampicillin plates was 12.1% lower than the number of colonies that appeared on the tetracycline plates; PCR analysis using TX1-and pJT48-specifi c primers indicated that 88.7% (71/80) of the colonies on the tetracycline plates were TX1/pJT48. Hence, the plasmid loss rate of pJT48 was at maximum 12.1%, which was comparable to that of pJRA ( 10%, Zhang et al., 2008) . Taken together, these results demonstrated that uncontrolled overexpression of acrR impaired the tissue dissemination and survival ability of TX1.
Identifi cation and analysis of a mutant AcrR that is only partially inducible
AcrR possesses an N-terminal DNA-binding motif (16 62) and a C-terminal effector domain (84 204) that are conserved among the TetR family of proteins. To examine the essentialness of the C-terminal region to the overall activity of AcrR, the plasmids pARD5, pARD12, pARD22, and pARD32, which express acrR bearing deletions of the C-terminal 5, 12, 22, and 32 residues respectively, were introduced into DH5α/ pSC284 by transformation. Subsequent β-galactosidase assays showed that the β-galactosidase activity of DH5α/pSC284/pARD32 was 321-fold more than that of DH5α/pSC284/pAR, but the β-galactosidase activities of all other transformants were comparable to that of DH5α/pSC284/pAR (Table 2) . These results indicated that the C-terminal 5, 12, and 22 amino acid residues were not essential to the activity of AcrR. When acrifl avine was present, the β-galactosidase activity of DH5α/pSC284/pARD5 was of the same level as that of DH5α/pSC284/pAR, whereas the β-galactosidase activities of DH5α/pSC284/pARD12 and DH5α/pSC284/ pARD22 were only one third of that of DH5α/pSC284/ pAR (Table 2) ; therefore the last 5 amino acid residues (Val 233 to Glu 237 ) of AcrR were not essential to the induction of P acrA but the 17 amino acid residues (Pro 216 to Cys 232 ) preceding Val 233 were required for full induction of P acrA by acrifl avine.
Since the mutant AcrR (named N215, Fig. 1 ) bearing deletion of the last 22 residues was only partially inducible and retained more repressor activity than the wild-type AcrR in the presence of the inducer (Table 2) , we examined its effect on AI-2 production and bacterial virulence. The results showed that the AI-2 activity produced by TX1 harboring pJN215, which expresses N215, was 15-fold less than that produced by TX1/ pJRA. Bacterial dissemination analyses (performed as described above) showed that the bacterial recovery from the livers of TX1/pJN215-infected fi sh was 29-fold less than the bacterial recovery from the livers of TX1/ pJRA-infected fi sh. Taken together, these results demonstrated that, like overexpression of the wild-type acrR, overexpression of N215 in TX1 attenuated AI-2 activity and bacterial virulence, but the effect of N215 appeared to be moderately stronger than that of the wild-type acrR.
Discussion
As multi-drug effl ux pumps, the AcrAB exporters of many bacterial species are responsible for resistance against a wide range of chemical and biochemical compounds that include antimicrobial agents, detergents, and dyes (Cobos et al., 2007; Su et al., 2007) . The genetic mechanism of multiple resistances involves the interaction of chemical compounds with AcrR and the subsequent induction of the AcrAB effl ux systems (Ahmed et al., 1994; Zgurskaya and Nikaido, Fig. 5 . Growth profi les of TX1/pJT48 and TX1/pJRA under different conditions. Cells grown overnight in LB medium were diluted to 1 10 6 CFU/ml in fresh LB medium supplemented with or without acrifl avine (AF, 10 μg/ml); growth was continued into the stationary phase and aliquots of the culture were taken at various time points for the measurement of absorbance at OD 600 .
2000). In TX1 we found that acrAB expression was required for resistance against acrifl avine and MV but not for resistance against tetracycline. In line with this observation, repression of acrAB expression by AcrR was relieved by acrifl avine and MV but not by tetracycline, chloramphenicol, or streptomycin, which are substrates of AcrAB pumps identifi ed in other bacteria. Although it is possible that in our system, in which the AcrR target promoter (i.e., P acrA ) exists in multiple copies, some subtle inducing effects may have escaped detection, these results nevertheless suggested that the TX1 AcrR may have an effector range, which partly defi nes the substrate range of the AcrAB pump, that is different from or more restricted compared to that of known AcrR.
In prokaryotic cells, transcriptional repression can happen via several mechanisms. Studies of the E. coli TetR and the Staphylococcus aureus QacR, a TetR-like repressor that controls the expression of the QacA multidrug transporter (Brown and Skurray, 2001) , have indicated that transcriptional inhibition of tetA by TetR is through blocking the access of RNA polymerase to the promoter whereas repression of qacA by QacR is via impeding the isomerization process (Grkovic et al., 1998) . In TX1, since the acrO site is located downstream of P acrR and overlaps P acrA , it is likely that inhibition of P acrA by AcrR is through spatial blockage which prevents the interaction between P acrA and RNA polymerase, whereas inhibition of P acrR is by hindering the formation of the DNA-RNA polymerase open complex that is required for transcriptional initiation. The observation that the repression of AcrR upon P acrA is stronger than that upon P acrR is supportive of this hypothesis, though it can also be accounted for by the fact that P acrR is a stronger promoter than P acrA and therefore is less repressible.
For pathogens that have to survive within a host it is vital to possess the facilities that enable them to cope with the unfavorable conditions encountered within the host environment, such as the presence of antibacterium compounds produced by the host. For this reason multidrug effl ux transporters constitute part of the virulence mechanisms that are important for bacterial infection and survival. Recently Posadas et al. (2007) have demonstrated that BepC, a TolC homologue identifi ed in Brucella suis, is involved in pathogenesis. In our study we found that disruption of the regulated expression of acrR by overexpressing acrR or N215 retarded the growth of TX1 under stress conditions caused by acrifl avine. These results raised the possibility that stress conditions induced by other yet unidentifi ed substrates of the AcrR/AcrAB system may also impair the growth and infectivity of TX1. The observation that acrR and N215 overexpression affected AI-2 activity suggested that AcrR may regulate not only the acrAB operon but also other cellular systems. Since the temporal production of AI-2 is required for full bacterial virulence, the reduction of AI-2 activity in TX1/pJT48 and TX1/pJN215 caused by acrR and N215 overexpression probably contributed to the decreased tissue dissemination and survival ability of these strains. Based on our result, it is reasonable to speculate that the TX1 AcrAB transporter is involved in the effl ux of biological compounds produced by the host as a defense mechanism against bacterial invasion; constitutive production of AcrR leads to constitutive repression of the acrAB operon and thus the accumulation of toxic compounds in the bacteria which in turn vitiates the survival ability of the pathogen.
